Zepbound is the same drug, but it is FDA-approved for weight loss in people with obesity
Some patients report that when things go wrong, such as shipping delays or billing issues, getting a timely resolution is frustrating
Storage and Handling Requirements AOD-9604 typically arrives in lyophilized (freeze-dried) powder form that requires reconstitution before use
11.8% weight loss achieved at 36 weeks in adults with obesity or overweight in VISTA Phase IIb trial HbA1c lowered by 1.9% at 26 weeks in adults with type 2 diabetes in SOLSTICE Phase IIb trial Extensive Phase III programme for elecoglipron planned including outcome trials 11.8% weight loss achieved at 36 weeks in adults with obesity or overweight in VISTA Phase IIb trial HbA1c lowered by 1.9% at 26 weeks in adults with type 2 diabetes in SOLSTICE Phase IIb trial Extensive Phase III programme for elecoglipron planned including outcome trials Positive results from the VISTA and SOLSTICE Phase IIb trials of elecoglipron, an oral small molecule GLP-1 receptor agonist (GLP-1 RA), unlock the next chapter in AstraZeneca's ambition to develop therapies that improve cardiometabolic and kidney health and reduce weight-related complications
The SELECT trial didnt measure cystatin C-based eGFR, to distinguish eGFR changes due to muscle mass
Despite its central role in pregnant women, this hormone has pleiotropic effects that are not exclusive to this population
